Abstract: Electronic health record (EHR) data can be extracted for calculating performance feedback, but users' perceptions of such feedback impact its effectiveness. Through qualitative analyses, we identified perspectives on barriers and facilitators to the perceived legitimacy of EHR-based performance feedback, in 11 community health centers (CHCs). Providers said such measures rarely accounted for CHC patients' complex lives or for providers' decisions as informed by this complexity, which diminished the measures' perceived validity. Suggestions for improving the perceived validity of performance feedback in CHCs are presented. Our findings add to the literature on EHR-based performance feedback by exploring provider perceptions in CHCs.
. This lack of trust in the legitimacy and accuracy of EHR-based performance feedback both stems from and illustrates the challenges of creating quality metrics based on readily extractable EHR data (Baker et al., 2007) .
Previous qualitative research identified some strategies for creating EHR data-based feedback measures that providers consider credible and valid, but with a few exceptions (Ivers et al., 2014a; Kansagara et al., 2014; Rowan et al., 2006) , this research was conducted in large, academic/integrated health care settings. Little is known about perceptions of and strategies for improving such feedback in the community health center (CHC) setting. Yet, CHCs-the United States' health care "safety net"-differ from other health care settings in critical ways, most notably their patients' socioeconomic vulnerability. Thus, there is a need to better understand barriers to the perceived legitimacy of EHR-based feedback measures in primary care CHCs, and approaches to crafting performance feedback that effectively improves care quality in this setting. To that end, we present an in-depth qualitative assessment of how primary care providers perceived EHRbased performance feedback, and their suggestions for increasing the utility of such feedback data, as reported in data collected in the context of a clinic-randomized implementation trial conducted in CHCs.
The terminology used to describe performance feedback in the literature varies. Here, performance metrics means the aggregate measurement of a given care point (eg, rate of guideline-concordant statin prescribing, shown as a percentage on a graph). Data feedback means potentially actionable data linked back to individual patients (eg, a list of patients with diabetes who are indicated for a statin but not prescribed one). Performance feedback encompasses both types of measurement.
METHODS
The "ALL Initiative" (ALL) is an evidencebased intervention designed to increase the percentage of patients with diabetes who are appropriately prescribed cardioprotective statins and angiotensin-converting enzyme inhibitors (ACEI)/angiotensin II receptor blockers (ARB). The data presented here were collected in the context of a 5-year pragmatic trial of the feasibility and impact of implementing ALL in 11 primary care CHCs in the Portland, Oregon, area. The ALL intervention included encounter-based alerts, patient panel data roster tools, and educational materials, described in detail elsewhere (Gold et al., 2012 (Gold et al., , 2015 . We also extracted data from the study CHCs' shared EHR to create performance metrics on the percentage of diabetic patients who had active prescriptions for statins and ACEI/ARBs, if indicated for those medications per national guidelines. These study-specific metrics were calculated for each clinic and clinician, using aggregated data (Figure 1) , and given to the study CHCs' leadership as monthly clinic-level reports; in addition, patient panel summaries were given to each provider at the study clinics at varying intervals. Individual patients' "indicated and active" status was also given to providers by request (Figure 2 ). The CHCs' leaders and individual providers distributed this performance feedback to clinic staff as desired; for details on how the feedback was disseminated, see Table 1 .
Using a convergent design within a mixedmethods framework (Fetters et al., 2013) , we collected qualitative data on the dynamics and contextual factors affecting intervention uptake (Bunce et al., 2014) . The extent of qualitative data collection at each clinic was informed by pragmatic constraints and data saturation (the point at which no new information was observed) (Guest et al., 2006) . Table 2 details our methods and sampling strategy. The intervention was implemented in June 2011 and supported through May 2015; qualitative data were collected between December 2011 and October 2014. Qualitative analysis was guided by the constant comparative method (Parsons, 2004) , wherein each finding and interpretation is compared to previous findings to generate theory grounded in the data. We used the software program QSR NVivo to organize and facilitate analysis of the interview and group discussion transcripts and observation field notes. We identified key emergent concepts, or codes, and assigned them to appropriate text segments. Each code's scope and definition was then refined, and additional themes identified, through iterative immersion/crystallization cycles (deep engagement with the data followed by reflection) (Borkan, 1999) . Our interpretations of the data were confirmed through regular discussions among the research team, which included experts in clinical care, quality improvement, and quantitative and qualitative research, and clinic leadership at the study CHCs. This study presents our qualitative findings on CHC physicians' perspectives on the performance feedback provided to them as described earlier.
This study was approved by the Kaiser Permanente NW Institutional Review Board. Study participants (clinic staff) gave verbal consent prior to data collection.
RESULTS

CHC providers' perceptions of performance feedback measures
CHC providers stated that they often questioned the validity of performance feedback measures, usually because the feedback measures did not account for CHC patients' needs or the complexity of their lives, or for clinical decisions made by providers who Figure 2 . Provider-specific data feedback. Kansagara et al., 2014; Kizer & Kirsh, 2012; Powell et al., 2012; Stange et al., 2014) , the socioeconomic vulnerabilities and fluidity of the CHC patient population added specific barriers to the perceived trustworthiness of the feedback measures.
Defining the population: Who counts as "indicated and active"?
In this study, the feedback measures' denominator was the number of patients indicated for a given medication (ACEI/ARB or statin), and the numerator was the number prescribed the indicated medication in the last year. However, CHC patients' socioeconomic circumstances (eg, lack of money to pay for the medication and housing instability) or related clinician judgment (eg, perceived likelihood of medication nonadherence and preference for a stepwise approach to prescribing for patients with complex needs) could be barriers to prescribing a given "indicated" medication. For example, some CHC patients bought medications in their home country, where they cost less, or took medications that family members or friends had discontinued. Without documentation of these circumstances in the EHR, however, the feedback measures would identify the patient's prescription as expired. Two examples illustrate this:
[Provider] asked about one medication that [the patient] said he was taking but it looked in the chart like he was out of. Patient explained that his son was taking the same medication but had recently been prescribed a higher dose, so he gave his dad (the patient) his remaining pills of the lower dose. "Because I don't have money." (Field note)
. . . If patients are not on the medications, it is not because it wasn't offered. [The provider] believes that if the patient was not on medications it is due to education level affecting understanding, lack of resources for scripts and tests, or patient flat out refuses. The concern . . . is how this information is reflected in the statistics or data. (Field note) Furthermore, CHC providers reported that their patients are often unable to see their primary provider for periods of time (eg, if they are out of the country, or in prison), or are not available for other reasons (eg, transient populations and inaccurate/frequently changing contact information). When patients on a provider's panel were temporarily receiving care elsewhere (eg, while in jail), and medication data were not shared between care sites, feedback measures would be affected. Similarly, migrant workers remain on the provider's panel (and thus in the feedback measures' denominator) even when they are out of the country and cannot be reached by the clinic. Their prescriptions might expire while the patient was unable to see their provider, negatively impacting rates of guideline-based prescribing in the performance feedback measures.
In addition, CHC patients are not enrolled members, which can affect measurement of care quality by making it unclear whether a patient was not receiving appropriate care, versus out of reach. Patients identified as lost to follow-up were removed from the feedback measures' denominators; however, as clinics used different methods for defining patients as lost to follow-up, accounting for this accurately in data extraction was difficult. For example, patients could be considered in a given provider's denominator if they were "touched" by the clinic in the last year (eg, by attempted phone calls) even if no actual contact was made. Thus, patients who were never seen in person could be included in the feedback measure's denominator.
Situations such as these could not be effectively captured by the extraction algorithm, as the EHR lacked discrete data fields where providers could record them, so these exceptions were not reflected in the performance data. As a result, the CHC providers often questioned the measures' validity and fairness. One provider said that receiving such reports can feel like "salt in the wound." Another provider noted:
. . . we get these stupid reports all the time telling you you're good, you're bad. I mean, just one less thing to like have somebody pointing fingers at me. . . . It's horrible as a provider, really, to get all of these measurements . . . It's like saying you're going to be graded on this. (PCP) Gap between potential and actuality Providers consistently described struggling between a desire to use feedback data to improve patient care and their inability to do so given inherent situational constraints. This could lead to feeling overwhelmed, anxious, frustrated, or guilty when they received the feedback reports.
. . . the possibilities for data and what we could do with it in a systematic way are amazing. But we are so completely overloaded . . . that we just can't even deal with the data that we get . . . (PCP) However, a few positives were noted. Some providers acknowledged that performance feedback can be helpful reminders of the importance of the targeted medications in diabetes care, which motivated them to discuss this with their patients.
I like it, personally, because . . . somebody is helping me to see. Sometimes it is difficult to see the whole picture . . . . It is not because you lack the knowledge or the experience. But you can't catch everything. (PCP) Others appreciated the feedback as a safeguard, even though they were often already aware of the patients flagged as needing specific actions or medications. Conversely, others thought it was not worth reviewing the reports, as they already knew their patients' issues: 
Provider suggestions for improving performance feedback measures
Despite the tensions described earlier, most providers said they wanted to receive feedback data, but many noted that organizational changes (eg, to workflow, staffing, and productivity expectations) would be necessary precursors to its effective use. Without these changes, providers thought such data would primarily serve as snapshots of current care quality, but not as tools to improve performance. They suggested a number of ways to improve both the acceptability and utility of performance feedback.
Staffing and resources
Dedicated, management-supported "brain time" was suggested as a means to enable care teams to review feedback data together and identify next steps to addressing care gaps. Providers also recommended designating a trusted team member (eg an RN) as responsible for identifying potentially actionable items from the feedback data. 
Action plans
Providers also requested concrete suggestions for how to prioritize and act on feedback data (along with resources to do so), saying that data alone are insufficient to drive change.
[What] I'd really like is here's your data, and here's what we're going to do with this. . . . Here's the twelve patients that you have six things wrong with them, that if you got these patients in they're really high yield, something like that. (PCP)
Holistic, patient-specific format
Many providers commented that patientlevel data would be more useful than aggregate performance metrics, and asked that such feedback data include patient-specific information along with the panel-based metrics. Many also requested that such patientlevel feedback data include relevant clinical indicators in addition to measures targeted by a given initiative (eg, a diabetes "dashboard" that shows HbA1c, blood pressure, and low-density lipoprotein results along with guideline-indicated medications) for a more holistic view of the patient's needs. I guess . . . if you were trending in the wrong direction that would be useful information . . . But for me . . . probably meatier is pulling lists and looking at specific individuals and saying, you know, here's this woman . . . she's not on statin . . . is there a reason why? (PCP) The patient panel data (Figure 2) , an example of this approach, were generally well-received by care teams. The colors are a "stoplight" tool: green indicated measurement within normal limits, yellow indicated that a measure approaching a concerning level, and red indicated a problem.
text documentation of patient refusal; to remove that patient from the measure denominator it is necessary to use the alert override option). In addition, the providers' ambivalence about the performance measures illuminates the need to acknowledge that care quality cannot be judged simplistically, and to ensure that focusing on measurement does not conflict with patient-centered care. Proactively acknowledging these needs and working with providers to address them could further strengthen trust in feedback measures.
This study has several limitations. The study clinics were involved in other, concurrent practice change efforts, some of which also involved performance feedback. Given this, provider reactions may have been atypical, limiting generalizability of the findings. Interviews and observations were conducted by members of the research team potentially perceived to have an investment in intervention outcomes; respondents may therefore have moderated their responses. Finally, results are purely descriptive and are not correlated with any quantitative outcomes.
CONCLUSION
Provider challenges to the legitimacy of EHR data-based performance feedback measures have impeded the effective use of such feedback. Addressing issues related to such measures' credibility and legitimacy, and providing strategies and resources to take action as necessary, may help realize the potential of EHR data-based performance feedback in improving patient care.
